Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy-Reference-Cited by-同舟云学术

Comparison of Abacavir/Lamivudine and Tenofovir/Emtricitabine Among Treatment-Naive HIV-Infected Patients Initiating Therapy

Published:2011-09-01 Issue:1 Volume:58 Page:38-46
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Tan Darrell H S,Chan Keith,Raboud Janet,Cooper Curtis,Montaner Julio S G,Walmsley Sharon,Hogg Robert S,Klein Marina B,Machouf Nima,Rourke Sean B,Tsoukas Chris,Loutfy Mona R

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference19 articles.

1. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.;Gazzard;HIV Med,2008

2. Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.;Sax;N Engl J Med,2009

3. Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV type-1: a randomized trial.;Daar;Ann Intern Med,2011

4. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.;Smith;AIDS,2009

5. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir.;Hetherington;Clin Ther,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An up-to-date evaluation of dolutegravir/abacavir/lamivudine for the treatment of HIV;Expert Opinion on Pharmacotherapy;2022-01-24

2. Abacavir + dolutegravir + lamivudine for the treatment of HIV;Expert Opinion on Pharmacotherapy;2016-09-13

3. Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations;Patient Preference and Adherence;2015-02

4. Reducing hypersensitivity reactions with HLA-B*5701 genotyping before abacavir prescription;Pharmacogenetics and Genomics;2015-02

5. Evaluation of dolutegravir safety for the treatment of HIV-1;Expert Opinion on Drug Safety;2014-10-27